Streptococcosis in Farmed Tilapia: Pathogenesis and Diagnostic Tools

Introduction

Streptococcosis represents one of the most economically significant bacterial disease complexes affecting global tilapia aquaculture. The primary etiological agents are Streptococcus agalactiae (Lancefield group B) and Streptococcus iniae. Both pathogens cause acute to chronic septicemia with characteristic neurological and ocular signs, leading to high morbidity and mortality in farmed Oreochromis spp. [1, 2]. The emergence of hypervirulent clonal lineages, such as S. agalactiae serotype Ia ST7 CC1, has intensified the need for robust diagnostic algorithms and pathogen-specific intervention strategies [2, 3].

This reference article provides an exhaustive review of streptococcosis pathogenesis and diagnostic tools, integrating recent genomic, immunological, and molecular findings. Emphasis is placed on the biophysical mechanisms of host-pathogen interaction, the physics of assay systems, and the clinical interpretation of diagnostic results.

Etiology and Host Range

Primary Pathogens

Two streptococcal species dominate tilapia disease outbreaks globally:

• Streptococcus agalactiae: A beta-hemolytic, Gram-positive coccus belonging to Lancefield group B. Capsular polysaccharide (CPS) serotypes Ia, Ib, and III are commonly isolated from tilapia. Serotype Ia ST7 strains have been associated with large-scale mortalities in Latin America, Asia, and Africa [2, 3, 4]. Non-tilapia freshwater fish also harbor S. agalactiae, indicating a broadening host range [5, 6].

• Streptococcus iniae: A beta-hemolytic, Gram-positive coccus that causes similar clinical presentations. Coinfections with S. agalactiae are reported, necessitating duplex detection methods [7].

Emerging Strains and Host Expansion

Recent outbreaks in hybrid marbled goby (Oxyeleotris spp.) demonstrate that S. agalactiae can cross species barriers within aquaculture systems [6]. Virulence gene profiling of isolates from non-tilapia freshwater fish reveals conserved sets of virulence determinants, including cps, cfb, scpB, and lmb [5]. Multidrug-resistant S. agalactiae strains harboring multiple antimicrobial resistance genes have been characterized from Nile tilapia, complicating treatment regimens [8].

Pathogenesis

Adhesion and Invasion

Streptococcal pathogenesis begins with adherence to host mucosal surfaces, primarily the gill and gastrointestinal epithelia. Surface adhesins such as laminin-binding protein (Lmb) and fibrinogen-binding proteins mediate initial attachment. Following colonization, bacteria translocate across epithelial barriers via paracellular and transcellular routes, entering the bloodstream to cause septicemia [9, 10, 11].

Immune Evasion

The polysaccharide capsule is the dominant antiphagocytic factor. CPS serotype Ia strains resist complement-mediated opsonization and phagocytosis by tilapia macrophages and neutrophils [3, 4]. Additional evasion mechanisms include:

• Degradation of host immunoglobulins by bacterial proteases.
• Modulation of host cytokine responses. For example, S. agalactiae infection upregulates interleukin (IL) gene expression in the spleen, including IL-1β, IL-8, and IL-10, which can suppress protective Th1 responses [11].
• Inhibition of interferon regulatory factor 5 (IRF5) signaling, a key mediator of the type I interferon response [10].
• Downregulation of interferon-stimulated gene 15 (ISG15), which normally enhances antiviral and antibacterial immunity [12].

Tissue Tropism and Clinical Pathology

Bacteria disseminate hematogenously to the central nervous system, eye, and visceral organs. Meningitis results from bacterial traversal of the blood-brain barrier, facilitated by interactions between streptococcal surface proteins and brain endothelial cells. In the eye, bacterial invasion of the retrobulbar space and vitreous humor produces exophthalmia and panophthalmitis. Histopathology reveals meningeal infiltration of lymphocytes and macrophages, perivascular cuffing, and focal necrosis in the liver, spleen, and kidney [2, 4, 11].

Age-Dependent Susceptibility

Studies in Latin American tilapia farms reveal that disease expression is age-dependent. Juvenile fish (less than 50 g) develop acute septicemia with high mortality, whereas larger fish (greater than 200 g) display chronic meningoencephalitis with lower but persistent mortality [2]. This differential susceptibility correlates with the maturation of the adaptive immune system and the expression of pattern recognition receptors.

Clinical Signs

Clinical presentation varies with pathogen strain, host age, and environmental stressors. The classic triad consists of:

• Neurological signs: Spiraling swimming, lethargy, loss of equilibrium, and corneal opacity.
• Ocular signs: Unilateral or bilateral exophthalmia with periocular hemorrhage.
• Systemic signs: Anorexia, darkening of the skin, and distended abdomen due to ascites.

Internal gross lesions include splenomegaly, hepatomegaly with focal necrosis, and congested meninges. Chronically infected fish may develop granulomatous lesions in the brain and kidney [2, 4].

Diagnostic Tools

Bacteriological Culture and Identification

Standard culture on blood agar or tryptic soy agar yields beta-hemolytic colonies after 24-48 hours at 28-30°C. Gram staining shows Gram-positive cocci in chains. Biochemical profiling (e.g., catalase-negative, bile esculin-positive for S. agalactiae) provides preliminary identification but lacks specificity for virulent strains.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays are the gold standard for species-level identification and serotyping. The SaSi qPCR assay is a novel duplex quantitative PCR that simultaneously detects S. agalactiae and S. iniae with high sensitivity and specificity, reducing turnaround time and cost [7]. Target genes include cfb (CAMP factor) for S. agalactiae and 16S rRNA for S. iniae.

Table 1: Common Molecular Targets for Streptococcal Detection in Tilapia

Multiplex PCR panels that include antimicrobial resistance genes (e.g., tetM, ermB, aadE) facilitate concurrent resistance profiling [8]. Whole-genome sequencing (WGS) using high-throughput sequencers provides definitive strain typing and phylogenetic analysis, enabling outbreak traceability.

Serological Assays

Enzyme-linked immunosorbent assay (ELISA) using monoclonal antibodies against CPS serotypes can quantify bacterial antigen in tissue homogenates and serum. This method is useful for epidemiological surveys but does not distinguish live from dead bacteria.

Antibiotic Sensitivity Testing

Disk diffusion and broth microdilution following Clinical and Laboratory Standards Institute (CLSI) guidelines (e.g., CLSI VET04) are standard. Key antibiotics tested include oxytetracycline, florfenicol, amoxicillin, and enrofloxacin. Alarmingly, multidrug resistance is increasingly reported. A study of multidrug-resistant S. agalactiae from Nile tilapia found resistance to tetracyclines, macrolides, and aminoglycosides, mediated by acquired resistance genes [8]. Silymarin, a plant flavonoid, has been shown to conserve the efficacy of quinolones and sulfonamides in aflatoxin-compromised tilapia, suggesting a role for adjunctive therapy [1].

Histopathology and Immunohistochemistry

Formalin-fixed, paraffin-embedded tissues stained with hematoxylin and eosin reveal characteristic lesions. Immunohistochemistry using anti-S. agalactiae polyclonal antibodies allows precise localization of bacteria within tissues.

Diagnostic Workflow

The following Mermaid diagram illustrates a recommended diagnostic decision tree for suspect streptococcosis outbreaks.

flowchart TD
    A[Clinical signs: exophthalmia, spiraling, mortality], > B[Gross necropsy: meningeal congestion, splenomegaly]
    B, > C{Sampling: brain, eye, spleen, kidney}
    C, > D[Bacteriological culture on blood agar]
    D, > E[Gram stain: Gram-positive cocci in chains]
    E, > F{Select PCR assay}
    F, > G[SaSi duplex qPCR: S. agalactiae / S. iniae]
    F, > H[Serotype-specific PCR: cps typing]
    G, > I[Confirm species & load]
    H, > J[Identify serotype]
    I, > K{Antibiotic sensitivity}
    J, > K
    K, > L[Disk diffusion / MIC]
    L, > M[Report: strain, serotype, resistance profile]
    M, > N[Implement treatment & biosecurity]

Immune Response and Vaccine Development

Understanding host immunity has accelerated vaccine design. CRISPR-Cas9-mediated construction of live attenuated S. agalactiae vaccines has shown protective efficacy in tilapia [9]. Alternatively, locally produced inactivated vaccines using outbreak strains offer a practical alternative to antibiotics in low-resource settings [13]. Selenium nano-vaccines incorporating S. pyogenes antigens have been evaluated for tilapia, though cross-protection against S. agalactiae requires further study [14]. Dietary interventions, such as α-mangostin-rich nanoemulsions combined with amino acids, enhance immune function and reduce streptococcal disease severity [15].

Antimicrobial Resistance and Stewardship

Antimicrobial resistance in streptococcal tilapia pathogens is a growing concern. Continuous monitoring of resistance profiles is essential. The emergence of multidrug-resistant S. agalactiae strains [8] underscores the need for prudent antimicrobial use and the integration of rapid diagnostics to guide therapy. Point-of-care molecular tools such as isothermal amplification assays could facilitate early detection on farms, but they are not yet widely validated for tilapia streptococcosis.

Conclusions

Streptococcosis in farmed tilapia continues to cause substantial economic losses. The pathogenesis involves complex interactions between bacterial virulence factors and host immune responses, with age-dependent outcomes. Diagnostic tools have evolved from culture-based methods to advanced molecular assays, including duplex qPCR and whole-genome sequencing, which enable rapid and precise pathogen identification, serotyping, and resistance profiling. Future efforts should focus on integrating these diagnostics with vaccine deployment and antimicrobial stewardship programs to achieve sustainable disease control in tilapia aquaculture.

References

[1] Haggag NA, Elbadawy M, ElKomy A, et al. Silymarin conserves the efficacy of quinolone and sulfonamide in Nile tilapia (Oreochromis niloticus) subjected to aflatoxicosis and Streptococcus agalactiae infection. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42230695/

[2] Rozas-Serri M, Fernandez-Alarcon M, Miyoko-Natori M, et al. Streptococcus agalactiae Serotype Ia ST7 CC1 in Farmed Nile Tilapia in Latin America: Age-Dependent Disease Expression and Antimicrobial Susceptibility of an Emerging Clonal Lineage. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42198670/

[3] LaFrentz BR, Barato P, Keleher WR, et al. Emergence, identification, and characterization of a novel Streptococcus agalactiae CPS type Ia ST7 strain (Ia-2021) causing large scale mortalities in tilapia aquaculture. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42106541/

[4] Avila-Castillo RA, Del Rio-Rodriguez RE, Soto-Rodriguez SA, et al. Confirmed Outbreaks of Streptococcosis Caused by Streptococcus agalactiae Serotype Ia in Nile Tilapia Culture From Campeche, Mexico. J Fish Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41844281/

[5] Hoai TD, Hoa DT, Anh NT, et al. Serotypes and Virulence Gene Profiles of Streptococcus agalactiae Isolates From Non-Tilapia Freshwater Fish. J Fish Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41622583/

[6] Wu W, Xu R, Sun Y, et al. Expansion of host range for Streptococcus agalactiae: first case in hybrid marbled goby (Oxyeleotris marmoratus ♀ × Oxyeleotris lineolatus ♂) from aquaculture. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41557120/

[7] Taengphu S, Dong HT, Meemetta W, et al. SaSi qPCR: a novel duplex qPCR assay for rapid and simultaneous detection of Streptococcus agalactiae and Streptococcus iniae in fish. BMC Res Notes. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41327378/

[8] Algammal AM, Mabrok M, Almessiry BK, et al. Unraveling the pathogenic potential, virulence traits, and antibiotic resistance genes of multidrug-resistant Streptococcus agalactiae strains retrieved from Nile tilapia. BMC Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41044671/

[9] Huang M, Li X, Pan T, et al. CRISPR-Cas9-mediated construction of a Streptococcus agalactiae vaccine for tilapia and evaluation of its protective efficacy. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42226151/

[10] Wei Y, Tan H, Gu C, et al. Characterization and functional analysis of the interferon regulatory factor 5 (IRF5) from the GIFT Oreochromis niloticus. Dev Comp Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41921286/

[11] Wang Z, Huang S, Liu H, et al. Genome-wide characterization of the interleukin gene family in Nile tilapia (Oreochromis niloticus) spleen: identification, expression dynamics, and regulatory mechanism during Streptococcus agalactiae infection. Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41391594/

[12] Wang Y, Tang W, Wu G, et al. Identification of an isg15 gene in Nile tilapia (Oreochromis niloticus) and analysis of its role in immune response modulation. Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41708017/

[13] Vinh NT, Dong HT, Turner JK, et al. Back to basics: locally produced vaccines offer a practical alternative to antibiotics for prevention of streptococcosis in farmed tilapia (Oreochromis spp.). Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41815501/

[14] Nasr-Eldahan S, Nabil-Adam A, Shreadah MA, et al. Effect of selenium nano-vaccine on hematological biomarkers and immune biochemical activity of nile tilapia (Oreochromis niloticus) challenged with Streptococcus pyogenes. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41272054/

[15] Srisaen W, Sutthi N, Rinthong PO, et al. Synergistic effects of α-mangostin-rich extract nanoemulsion and a natural free amino acid mixture on growth performance, immune function, intestinal microbiota, and disease resistance in Nile tilapia (Oreochromis niloticus). Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41253207/